StudyFinds' Dr. Faith Coleman looks at the common mistakes patients make using GLP-1 agonists like Ozempic and Wegovy.

The Government is considering using drugs to help get obese people back to work - but they can lead to serious health ...

A recent study published by the Journal of the American Medical Association (JAMA) found that patients taking the drugs ...

Diabetes medications like Ozempic and Trulicity are typically covered, while weight loss drugs like Wegovy and Saxenda face ...

We recently compiled a list of the 10 Most Promising Growth Stocks According to Hedge Funds. In this article, we are going to ...

The British government announced a multimillion dollar pharmaceutical partnership with Eli Lilly, including a trial that will ...

Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug ...

Retired Oak Ridge, Tennessee, physician notes the downside of a class of drugs − GLP-1s − first approved for treating ...

Britain will study whether the use of Eli Lilly's weight loss drug can get people back into work and help tackle the high ...

The U.K. is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with weight-loss treatment giant, Eli Lilly.

New phase 3b trial results show Lilly’s Trulicity has helped type 2 diabetes patients already taking an SGLT2 inhibitor but whose blood sugar was inadequately controlled. The AWARD trial showed ...

A study on the "real-world" effectiveness of weight loss drugs is set to measure the impact on the job prospects of people ...